A protocol of a clinical trial with a design that allows testing multiple drugs and/or multiple subpopulations in parallel is called a master protocol. Master protocols offer opportunities to accelerate drug development and scientific learning. For this webinar, PSI brings together experts on master protocols from the pharmaceutical industry, academia, and regulatory agencies.
Join us to hear Martin Posch (Medical University of Vienna), Hans-Joachim Helms (Roche) and Andrew Thomson (EMA) present about current statistical issues in platform trials, an introduction to the MORPHEUS program and a regulatory view on platform trials.
The webinar will take place on Wednesday 23 September from 14.00 to 16.00.